Tilray | TRLY - SCHULD

Aktienkurs
9.11
Täglich Wechseln
-0.15 -1.62%
Monatlich
-8.63%
Jährlich
1,323.44%
Q2 Prognose
8.92




SCHULD Veränderung Datum
Acasti Pharma USD 0 0 2024-09
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Avita Medical AUD 46.05M 1.46M 2025-12
Canopy Growth CAD 259.33M 68.47M 2025-09
Cronos Group USD 1.74M 269K 2025-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
IQVIA Holdings USD 15.72B 767M 2025-12
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Moderna USD 734M 7M 2025-09
Organon & Co USD 8.83B 68M 2025-09
Revvity USD 3.37B 5.86M 2025-09
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Viatris USD 14.41B 25.6M 2025-12
Xeris Pharmaceuticals USD 257.65M 431K 2025-09